COST vs PFE: Which Is the Better Buy?
Side-by-side comparison of Costco Wholesale Corporation and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-05.
Costco Wholesale Corporation · Consumer Defensive
$999.89
-20.7% upside to fair value
Grade D
High Quality
VS
Pfizer Inc. · Healthcare
$26.33
+28.6% upside to fair value
Grade B
QuantHub Verdict
PFE has more upside to fair value
(+28.6%).
PFE trades at a lower forward P/E
(19.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
COST |
PFE |
| Current Price |
$999.89 |
$26.33 |
| Fair Value Estimate |
$793.02 |
$33.85 |
| Upside to Fair Value |
-20.7%
|
+28.6%
|
| Market Cap |
$443.6B |
$149.8B |
| Forward P/E |
51.9x
|
19.3x
|
| EV / EBITDA |
30.9x
|
12.9x
|
| Price / Sales |
1.6x
|
2.4x
|
| Price / FCF |
48.8x
|
16.5x
|
| Revenue Growth YoY |
+9.2%
|
-1.2%
|
| Gross Margin |
12.9%
|
70.3%
|
| Operating Margin |
3.8%
|
24.7%
|
| Return on Equity |
28.8%
|
8.7%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.05%
|
6.06%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
Costco Wholesale Corporation operates a global membership-based warehouse club model that leverages scale, low costs, and superior employee retention to deliver consistent revenue and earnings growth. The company reported $269.9 billion in net sales for fiscal 2025 with an 8% year-over-year increase, driven by strong segments in Foods and Sundries and membership fees exceeding $5.65 billion in th…
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…
Accumulation Zones
| Metric |
COST |
PFE |
| Zone Low |
$594.76 |
$25.39 |
| Zone High |
$674.07 |
$28.77 |
| In Buy Zone? |
No
|
Yes
|